Market Cap $427.0M
!
Corporate Spotlight
Racura Oncology (ASX: RAC) is a Phase 3 clinical biopharmaceutical company with a dedicated mission to be at the heart of cancer care.
View the full Corporate Spotlight
INSIDE RACURA ONCOLOGY - 2026 OUTLOOK
Last update - 16.13pm 12/03/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | $2.40 | Day High | $2.40 | Day Low | $2.26 | |||
| Daily Volume | 94196 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | $2.28 | 285 | 0 | $2.32 | 4000 | |
Directors & Senior Management
| Dr. Borje S. Andersson | Chairman of Clinical Advisory Board |
| Mr. Brendan Brown | Chief Financial Officer |
| Mr. Brendan Brown | Chief Financial Officer |
| Dr. Daniel Douglas Von Hoff | Clinical Advisory Board |
| Dr. Daniel Tillett | CEO, MD & Director |
| Dr. Daniel Tillett | Chief Executive Officer, Managing Director |
| Dr. Douglas Smith | Member of Scientific Advisory Board |
| Associate Prof. Erin Howden | Member of Scientific Advisory Board |
| Dr. Jaap-Jan Boelens | Member of Clinical Advisory Board |
| Dr. James Breitenbucher | Member of Scientific Advisory Board |
| Prof. Jianjun Chen | Member of Scientific Advisory Board |
| Dr. Jose L. Iglesias | Chief Medical Officer |
| Dr. Laurence H. Hurley | Member of Scientific Advisory Board |
| Dr. Martin S. Tallman | Member of Scientific Advisory Board |
| Dr Megan Baldwin | Non-Executive Director |
| Dr. Megan Baldwin | Independent Non-Executive Director |
| Mr. Peter Gordon Webse | Company Secretary |
| Dr. Peter Michael Smith | Executive Chairman |
| Dr. Roland Walter | Member of Scientific Advisory Board |
| Dr. Serge Scrofani | Non-Executive Director |
| Dr. Serge Scrofani | Independent Non-Executive Director |
| Dr. Sophia Moscovis | Vice President of Operations & Strategy |
| Dr. Sophia Moscovis | Vice President of Operations and Strategy |
Data source: ADVFN